TD Cowen Maintains Buy on Calumet, Raises Price Target to $27
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Jason Gabelman maintains a Buy rating on Calumet (NASDAQ:CLMT) and raises the price target from $22 to $27.
October 17, 2024 | 5:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Jason Gabelman has reiterated a Buy rating for Calumet and increased the price target from $22 to $27, indicating a positive outlook.
The Buy rating and increased price target from a reputable analyst suggest a positive sentiment towards Calumet's stock, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100